Patent details
EP3592772 Title: ANTI CCL24 (EOTAXIN2) ANTIBODIES FOR USE IN THE TREATMENT OF HEPATIC DISEASES
Basic Information
- Publication number:
- EP3592772
- PCT Application Number:
- IL2018050276
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP187171350
- PCT Publication Number:
- WO2018163185
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ANTI CCL24 (EOTAXIN2) ANTIBODIES FOR USE IN THE TREATMENT OF HEPATIC DISEASES
- French Title of Invention:
- ANTICORPS ANTI-CCL24 (EOTAXIN2) DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DE MALADIES HÉPATIQUES
- German Title of Invention:
- ANTI-CCL24 (EOTAXIN2)-ANTIKÖRPER ZUR VERWENDUNG BEI DER BEHANDLUNG VON LEBERERKRANKUNGEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 16/04/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 23/04/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 20/03/2024
- Unitary Effect Registration Date:
- 23/04/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 08/03/2018
- Grant date:
- 20/03/2024
- EP Publication Date:
- 15/01/2020
- PCT Publication Date:
- 13/09/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 20/03/2024
- EP B1 Publication Date:
- 20/03/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 08/03/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 13/03/2024
- Name:
- Chemomab Ltd.
- Address:
- Kiryat Aditim Building 7 Entrance B, 6158002 Tel Aviv, Israel (IL)
Inventor
- Name:
- MOR, Adi
- Address:
- Israel (IL)
Priority
- Priority Number:
- 25102417
- Priority Date:
- 08/03/2017
- Priority Country:
- Israel (IL)
Classification
- IPC classification:
- C07K 16/24;
Publication
European Patent Bulletin
1
- Issue number:
- 202412
- Publication date:
- 20/03/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202421
- Publication date:
- 22/05/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202421
- Publication date:
- 22/05/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|